Evidence map›Paper›PMID 37123194›Full record

ArticleChemical science2023

Structure-guided semi-rational design of an imine reductase for enantio-complementary synthesis of pyrrolidinamine.

Jun Zhang, Yaqing Ma, Fangfang Zhu, Jinping Bao, Qiaqing Wu, Shu-Shan Gao, Chengsen Cui

Abstract read
In one paragraph

Article in Chemical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jun ZhangTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences Tianjin 300308 China gaoss@tib.cas.cn cuichs@tib.cas.cn.ORCID https://orcid.org/0000-0001-9250-9450
Yaqing MaTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences Tianjin 300308 China gaoss@tib.cas.cn cuichs@tib.cas.cn.
Fangfang ZhuTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences Tianjin 300308 China gaoss@tib.cas.cn cuichs@tib.cas.cn.
Jinping BaoTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences Tianjin 300308 China gaoss@tib.cas.cn cuichs@tib.cas.cn.
Qiaqing WuTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences Tianjin 300308 China gaoss@tib.cas.cn cuichs@tib.cas.cn.ORCID https://orcid.org/0000-0001-7405-1562
Shu-Shan GaoTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences Tianjin 300308 China gaoss@tib.cas.cn cuichs@tib.cas.cn.
Chengsen CuiTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences Tianjin 300308 China gaoss@tib.cas.cn cuichs@tib.cas.cn.ORCID https://orcid.org/0000-0002-6867-1826

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, engineered imine reductases (IREDs) of IRED M5, originally from

Identifiers

PMID37123194
PMCPMC10132124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.